SEC Form 4 · accession 0001022079-16-000263
QUEST DIAGNOSTICS INC · DGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jenne K Britell
Director
Period of report
May 12, 2016
Accepted (ET)
May 16, 2016 · 4:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001022079
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 12, 2016 | M | 8,000 | $51.55 | A | 19,655 | I | by Trust |
| Common StockF1,F2 | May 12, 2016 | S | 8,000 | $75.682 | D | 11,655 | I | by Trust |
| Common StockF3 | holding | — | — | — | 6,025 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F4 | $51.55 | May 12, 2016 | M | 8,000 | D | — | May 14, 2019 | Common Stock | 8,000 | 0 | I |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $75.67 to $75.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provideupon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2Shares reported as directly held on reporting person's previous Form 4 filing were subsequently transferred to a family trust in a transaction exempt from Section 16 under Rule 16a-13.
- F3The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.
- F4The options vested in three equal annual installments beginning with the first on May 14, 2010, the second on May 14, 2011 and the final on May 14, 2012.